Table 5 Analysis assessing diet and sex interactions concerning anthropometric and biochemical markers

From: Short-term role of the dietary total antioxidant capacity in two hypocaloric regimes on obese with metabolic syndrome symptoms: the RESMENA randomized controlled trial

Variable	Groups				ANOVA 2×2
	Control-men (n = 27)	Control-women (n = 21)	RESMENA-men (n = 24)	RESMENA-women (n = 24)	DIET	SEX	Diet* sex
ΔWeight (Kg)	−7.60 ± 3.29	−5.61 ± 2.49	−7.73 ± 2.58	−6.45 ± 3.09	0.416	0.007	0.550
ΔBMI (kg/m²)	−2.56 ± 1.12	−2.29 ± 1.03	−2.55 ± 0.90	−2.49 ± 1.10	0.677	0.452	0.620
ΔWaist circumference (cm)	−6.57 ± 4.02	−7.01 ± 5.87	−8.15 ± 2.88	−6.80 ± 4.65	0.454	0.620	0.324
ΔBioimpedance Fat mass (kg)	−6.08 ± 4.92	−4.28 ± 1.84	−5.90 ± 2.64	−4.89 ± 3.50	0.764	0.054	0.582
ΔDXA Fat mass (kg)	−5.13 ± 2.80	−3.99 ± 1.49	−5.71 ± 1.95	−4.78 ± 2.75	0.156	0.034	0.835
ΔTotal Cholesterol (mg/dl)	−15.31 ± 35.58	−19.05 ± 30.86	−22.25 ± 44.19	−10.42 ± 49.55	0.921	0.635	0.362
ΔHDL-c (mg/dl)	−2.01 ± 7.10	−6.67 ± 6.98	−0.61 ± 7.29	−3.32 ± 6.03	0.098	0.011	0.495
ΔLDL-c (mg/dl)	−6.12 ± 25.04	−7.48 ± 27.41	−10.82 ± 40.17	−0.51 ± 47.30	0.880	0.553	0.440
ΔTG (mg/dl)	−35.88 ± 78.11	−24.50 ± 61.90	−54.08 ± 88.48	−32.96 ± 69.79	0.399	0.304	0.757
ΔGlucose (mg/dl)	−18.53 ± 36.01	−5.91 ± 19.86	−7.33 ± 26.55	−19.84 ± 46.17	0.847	0.994	0.079
ΔInsulin (IU/mg)	−7.68 ± 9.02	−3.37 ± 3.58	−6.26 ± 5.02	−4.16 ± 5.25	0.690	0.022	0.486
ΔHOMA	−2.64 ± 2.65	−1.35 ± 1.68	−1.74 ± 1.63	−2.02 ± 2.83	0.818	0.293	0.099
ΔALT (U/L)	−13.68 ± 19.36	−6.52 ± 12.77	−3.33 ± 10.70	3.64 ± 15.38	0.001	0.026	0.975
ΔAST (U/L)	−6.49 ± 11.74	−3.37 ± 6.16	−0.28 ± 6.13	0.88 ± 6.51	0.003	0.210	0.562

BMI, Body Mass Index; DXA, Dual-energy X-ray Absorptiometry; HDL-c, High Density Lipoprotein-cholesterol; LDL-c, Low Density Lipoprotein-cholesterol; TG, Triglycerides; HOMA, Homeostasis Model Assessment; ALT, Alanine aminotransferase; AST, Aspartate aminotranferase. p < 0.05 was set-up as statistically significant.

Back to article page